PetLife Pharmaceuticals, Inc. 10-K, filed Dec 21, 2016: IDEA: XBRL DOCUMENT
Income Taxes - Schedule of Provision for Refundable Federal Income Tax (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Aug. 31, 2016 |
Aug. 31, 2015 |
|
| Income Tax Disclosure [Abstract] | ||
| Net operating loss | $ 1,254,000 | $ 657,000 |
| Valuation allowance | (1,254,000) | (657,000) |
| Net benefit | ||